Skip to main content
. Author manuscript; available in PMC: 2021 Dec 17.
Published in final edited form as: Biochem Biophys Res Commun. 2020 Sep 28;533(4):739–744. doi: 10.1016/j.bbrc.2020.09.033

Fig. 3. IFT20 plays a role in the regulation of FKBP65 expression.

Fig. 3.

(A) qRT-PCR analysis for Ift20, and Fkbp10, and Plod2 in WT and Ift20 mutant osteoblasts from Ift20:Wnt1-Cre skull tissues. (B) Western blot analysis for FKBP65, LH2 and IFT20 from WT and Ift20:Wnt1-Cre skull tissues. (C) FKBP65 expression in Ift20:Ocn-Cre skull tissues was examined by immunohistochemistry. (D) A mechanism by which IFT20 controls the expression of PTM regulator (FKBP65) in bone formation. Data in (A) and (B) represented as mean ± SD; n=3 in each group. *P<0.05.